Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Mvasi® Page last updated: 2 July 2021 Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 787KB) Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 44KB)